Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study

BACKGROUND: Data on medium-term outcomes in indivduals with myocarditis after mRNA COVID-19 vaccination are scarce. We aimed to assess clinical outcomes and quality of life at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults. METHODS: In this f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kracalik, Ian, Oster, Matthew E, Broder, Karen R, Cortese, Margaret M, Glover, Maleeka, Shields, Karen, Creech, C Buddy, Romanson, Brittney, Novosad, Shannon, Soslow, Jonathan, Walter, Emmanuel B, Marquez, Paige, Dendy, Jeffrey M, Woo, Jared, Valderrama, Amy L, Ramirez-Cardenas, Alejandra, Assefa, Agape, Campbell, M Jay, Su, John R, Magill, Shelley S, Shay, David K, Shimabukuro, Tom T, Basavaraju, Sridhar V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555956/
https://www.ncbi.nlm.nih.gov/pubmed/36152650
http://dx.doi.org/10.1016/S2352-4642(22)00244-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555956/
https://www.ncbi.nlm.nih.gov/pubmed/36152650
http://dx.doi.org/10.1016/S2352-4642(22)00244-9

Ejemplares similares